523 related articles for article (PubMed ID: 32942797)
1. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
Kaye RJ
Pain Physician; 2020 Aug; 23(4S):S421-S432. PubMed ID: 32942797
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
3. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal Membrane Oxygenation for Severe Respiratory Failure During Respiratory Epidemics and Pandemics: A Narrative Review.
Lim JKB; Qadri SK; Toh TSW; Lin CB; Mok YH; Lee JH
Ann Acad Med Singap; 2020 Apr; 49(4):199-214. PubMed ID: 32296808
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
[TBL] [Abstract][Full Text] [Related]
6. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
7. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
[TBL] [Abstract][Full Text] [Related]
8. Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.
Xia J; Feng Y; Li M; Yu X; Zhang Y; Duan J; Zhan Q
BMC Infect Dis; 2020 Aug; 20(1):637. PubMed ID: 32854630
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
[TBL] [Abstract][Full Text] [Related]
10. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
11. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835
[TBL] [Abstract][Full Text] [Related]
12. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
Wang XY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
[TBL] [Abstract][Full Text] [Related]
13. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
15. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
[No Abstract] [Full Text] [Related]
16. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
Fan E; Beitler JR; Brochard L; Calfee CS; Ferguson ND; Slutsky AS; Brodie D
Lancet Respir Med; 2020 Aug; 8(8):816-821. PubMed ID: 32645311
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
19. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
[TBL] [Abstract][Full Text] [Related]
20. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
